Amedrix is a startup based in Germany, most recent round Acquired, 1 tracked investor.
Amedrix is a company headquartered in Germany. Amedrix has been acquired. Brouky records 1 investor associated with the company.
Amedrix is a German medical technology company that develops, produces, and distributes collagen-based implants for regenerative medicine, focusing on the repair of cartilage and bone defects.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.